BOULDER, Colo., Sep 13, 2010 (BUSINESS WIRE) --
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief
Executive Officer, Robert E. Conway, will speak at the UBS Global Life
Sciences Conference in New York City. The public is welcome to
participate in the conference through a webcast on the Array BioPharma
website.
|
Event:
|
|
UBS Global Life Sciences Conference
|
|
Presenter:
|
|
Robert E. Conway, Chief Executive Officer, Array BioPharma
|
|
Date:
|
|
Monday, September 20, 2010
|
|
Time:
|
|
1:30 p.m. Eastern Time
|
|
Location:
|
|
The Grand Hyatt New York, NY
|
|
Webcast:
|
|
www.arraybiopharma.com
|
|
|
|
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the
discovery, development and commercialization of targeted small molecule
drugs to treat patients afflicted with cancer and inflammatory diseases.
Our proprietary drug development pipeline includes clinical candidates
that are designed to regulate therapeutically important target proteins
and are aimed at significant unmet medical needs. For more information
on Array, please go to www.arraybiopharma.com.
SOURCE: Array BioPharma Inc.
Array BioPharma Inc.
Tricia Haugeto, 303-386-1193
thaugeto@arraybiopharma.com
